Pfizer said Monday that an early peek at the data on its coronavirus vaccine suggests the shots may be a robust 90% effective at preventing COVID-19, putting the company on track to apply later this month for emergency-use approval from the Food and Drug Administration.
Related posts
-
Ping pong pain: Tiebreaker proves costly to Bulls as Dallas wins draft lottery
The bad luck continued for the Bulls at Monday’s NBA Draft Lottery. They stayed put at... -
A ‘generational project’: Naperville ready to revisit 5th Avenue redevelopment potential
Naperville officials have enlisted the Urban Land Institute to help reimagine the 5th Avenue area near... -
Officials: $32 million Arlington Heights park refresh won’t disrupt Frontier Days
The Arlington Heights Park District is embarking on the final phases of a $32 million renovation...